Literature DB >> 21106781

The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant.

Philippe Simon1, Benjamin P Holder, Xavier Bouhy, Yacine Abed, Catherine A A Beauchemin, Guy Boivin.   

Abstract

Oseltamivir-resistant A/H3N2 influenza isolates with or without the E119V and I222V neuraminidase (NA) mutations were recovered from an immunocompromised patient. Based on plaque size, yield assays, and NA activity, the impaired viral fitness of the E119V mutant was partially restored by the I222V NA mutation.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21106781      PMCID： PMC3043469          DOI： 10.1128/JCM.01732-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor.

Authors:  Shuji Hatakeyama; Yuko Sakai-Tagawa; Maki Kiso; Hideo Goto; Chiharu Kawakami; Keiko Mitamura; Norio Sugaya; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.

Authors:  Hui-Ling Yen; Louise M Herlocher; Erich Hoffmann; Mikhail N Matrosovich; Arnold S Monto; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

4.  Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.

Authors:  Margaret Okomo-Adhiambo; Gail J Demmler-Harrison; Varough M Deyde; Tiffany G Sheu; Xiyan Xu; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

5.  Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.

Authors:  Mariana Baz; Yacine Abed; Jane McDonald; Guy Boivin
Journal:  Clin Infect Dis       Date:  2006-11-08       Impact factor: 9.079

6.  Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

Authors:  M Louise Herlocher; Rachel Truscon; Stephanie Elias; Hui-Ling Yen; Noel A Roberts; Suzanne E Ohmit; Arnold S Monto
Journal:  J Infect Dis       Date:  2004-09-28       Impact factor: 5.226

7.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

8.  Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.

Authors:  Nicole M Bouvier; Anice C Lowen; Peter Palese
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

9.  New low-viscosity overlay medium for viral plaque assays.

Authors:  Mikhail Matrosovich; Tatyana Matrosovich; Wolfgang Garten; Hans-Dieter Klenk
Journal:  Virol J       Date:  2006-08-31       Impact factor: 4.099

Review 10.  Treatment of respiratory virus infections.

Authors:  Yacine Abed; Guy Boivin
Journal:  Antiviral Res       Date:  2006-02-14       Impact factor: 5.970
View more
  22 in total

1.  Ancestral and Compensatory Mutations that Promote Antiviral Resistance in Influenza N1 Neuraminidase Revealed by a Phylonumerics Approach.

Authors:  Elma H Akand; Kevin M Downard
Journal:  J Mol Evol       Date:  2018-10-09       Impact factor: 2.395

Review 2.  Fitness of neuraminidase inhibitor-resistant influenza A viruses.

Authors:  Tatiana Baranovich; Robert G Webster; Elena A Govorkova
Journal:  Curr Opin Virol       Date:  2011-10-01       Impact factor: 7.090

3.  Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.

Authors:  Henju Marjuki; Vasiliy P Mishin; Anton P Chesnokov; Joyce Jones; Juan A De La Cruz; Katrina Sleeman; Daisuke Tamura; Ha T Nguyen; Ho-Sheng Wu; Feng-Yee Chang; Ming-Tsan Liu; Alicia M Fry; Nancy J Cox; Julie M Villanueva; Charles T Davis; Larisa V Gubareva
Journal:  J Infect Dis       Date:  2014-08-14       Impact factor: 5.226

4.  Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.

Authors:  Andrés Pizzorno; Yacine Abed; Xavier Bouhy; Edith Beaulieu; Corey Mallett; Rupert Russell; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

Review 5.  Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.

Authors:  Jennifer L McKimm-Breschkin
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

6.  Expected Effect of Deleterious Mutations on Within-Host Adaptation of Pathogens.

Authors:  Judith M Fonville
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

7.  Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model.

Authors:  Benjamin P Holder; Philippe Simon; Laura E Liao; Yacine Abed; Xavier Bouhy; Catherine A A Beauchemin; Guy Boivin
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

8.  Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water.

Authors:  Anna Gillman; Marie Nykvist; Shaman Muradrasoli; Hanna Söderström; Michelle Wille; Annika Daggfeldt; Caroline Bröjer; Jonas Waldenström; Björn Olsen; Josef D Järhult
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

9.  Simultaneous detection of oseltamivir- and amantadine-resistant influenza by oligonucleotide microarray visualization.

Authors:  Yingjie Zhang; Qiqi Liu; Dou Wang; Suhong Chen; Shengqi Wang
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

Review 10.  Influenza treatment and prophylaxis with neuraminidase inhibitors: a review.

Authors:  Amanda Kamali; Mark Holodniy
Journal:  Infect Drug Resist       Date:  2013-11-19       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.